Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.04 EUR | +1.86% |
|
-3.59% | -8.85% |
11:02am | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
10:45am | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Evolution of the average Target Price on Takeda Pharmaceutical Company Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Takeda Pharmaceutical Company Limited
Jefferies & Co. | |
TD Cowen | |
BofA Securities | |
Cowen | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- 4502 Stock
- TKD Stock
- Consensus Takeda Pharmaceutical Company Limited